Good Clinical Practice (Answered)
2025/2026. 100% Verified. 101 Q&A.
Which of the following best describes the principle of Respect for Persons as Described in the
Belmont Report?
a) Risk/benefit assessment, justification of research, comprehension
b) comprehension, conflicts of interest, risk/benefit ration
c) information, comprehension, voluntariness
d) voluntariness, risk/benefit assessment. selection of subjects.
C
________________is the degree to which, or the rate at which, a medication or other substance is
absorbed or becomes available at the targeted place in the body.
Bioavailability
___________________ means that subjects are split into at least two groups: those receiving the
experimental agent and those receiving a standard treatment for the condition (an active control),
no treatment, or a placebo. If subjects are assigned randomly into these groups, the study is a
randomized controlled trial.
Controlled
______________ is a standard for the design, conduct, performance, monitoring, auditing,
recording, analyses, and reporting of clinical trials.
Good Clinical Practice (GCP)
__________________ describes the effects of the agent while in the body.
Pharmacodynamics
________________is the use of genetic information to predict whether a drug will help make a
patient well or ill.
Pharmacogenomics
___________________________describes how the agent moves through and is excreted from the
body.
Pharmacokinetics
The first step in the drug-development process allows investigators to evaluate the drug using tissue
cultures and animal models. This research is referred to as ______________.
preclinical studies
_________________ is a compilation of the pre-clinical and clinical data on the investigational
product(s) that are relevant to the study of the product(s) in human subjects.
The Investigator's Brochure (IB)
, ICH E6 also defines what a "____________________" of the original record is. In order for a record
to be (this), the paper or electronic copy of the original record must have been verified (for example,
by a dated signature) or generated through a validated process to produce an exact copy of the
original.
Certified Copy
The first Investigator's Brochure IB for a proposed clinical trial of a new drug is based primarily on
which of the following?
a) preclinical trials
b) Phase II studies.
preclinical trials
Development of most new drugs, from discovery to marketing approval, usually takes:
A) 5 years
B) Less than 5 months
C) 1-3 years
D) 9 years or more
D
Adults with more than a twelve (12)-month history of migraines were assigned randomly in a
double-blinded study to receive treatment with experimental drug X (10 or 20 mg/day) or placebo.
The primary efficacy measure was the reduction in severity of the migraine attacks. Enrollment was
twelve-hundred (1200) subjects. Which of the following best describes the clinical phase of this
study?
A) Phase II
B) Phase III
C) Pre-clinical
D) Phase I
B
Long-term toxicology of an experimental drug in animals most likely refers to which part of drug
development?
A) Phase II
B)Pre-clinical
C) Phase I
D) Phase III
B
Pharmacokinetics and pharmacodynamics of a new formulation of an investigational drug most likely
refers to which clinical phase of a study in humans?
A) Phase II
B) Pre-clinical
C) Phase I
D) Phase III
C
2025/2026. 100% Verified. 101 Q&A.
Which of the following best describes the principle of Respect for Persons as Described in the
Belmont Report?
a) Risk/benefit assessment, justification of research, comprehension
b) comprehension, conflicts of interest, risk/benefit ration
c) information, comprehension, voluntariness
d) voluntariness, risk/benefit assessment. selection of subjects.
C
________________is the degree to which, or the rate at which, a medication or other substance is
absorbed or becomes available at the targeted place in the body.
Bioavailability
___________________ means that subjects are split into at least two groups: those receiving the
experimental agent and those receiving a standard treatment for the condition (an active control),
no treatment, or a placebo. If subjects are assigned randomly into these groups, the study is a
randomized controlled trial.
Controlled
______________ is a standard for the design, conduct, performance, monitoring, auditing,
recording, analyses, and reporting of clinical trials.
Good Clinical Practice (GCP)
__________________ describes the effects of the agent while in the body.
Pharmacodynamics
________________is the use of genetic information to predict whether a drug will help make a
patient well or ill.
Pharmacogenomics
___________________________describes how the agent moves through and is excreted from the
body.
Pharmacokinetics
The first step in the drug-development process allows investigators to evaluate the drug using tissue
cultures and animal models. This research is referred to as ______________.
preclinical studies
_________________ is a compilation of the pre-clinical and clinical data on the investigational
product(s) that are relevant to the study of the product(s) in human subjects.
The Investigator's Brochure (IB)
, ICH E6 also defines what a "____________________" of the original record is. In order for a record
to be (this), the paper or electronic copy of the original record must have been verified (for example,
by a dated signature) or generated through a validated process to produce an exact copy of the
original.
Certified Copy
The first Investigator's Brochure IB for a proposed clinical trial of a new drug is based primarily on
which of the following?
a) preclinical trials
b) Phase II studies.
preclinical trials
Development of most new drugs, from discovery to marketing approval, usually takes:
A) 5 years
B) Less than 5 months
C) 1-3 years
D) 9 years or more
D
Adults with more than a twelve (12)-month history of migraines were assigned randomly in a
double-blinded study to receive treatment with experimental drug X (10 or 20 mg/day) or placebo.
The primary efficacy measure was the reduction in severity of the migraine attacks. Enrollment was
twelve-hundred (1200) subjects. Which of the following best describes the clinical phase of this
study?
A) Phase II
B) Phase III
C) Pre-clinical
D) Phase I
B
Long-term toxicology of an experimental drug in animals most likely refers to which part of drug
development?
A) Phase II
B)Pre-clinical
C) Phase I
D) Phase III
B
Pharmacokinetics and pharmacodynamics of a new formulation of an investigational drug most likely
refers to which clinical phase of a study in humans?
A) Phase II
B) Pre-clinical
C) Phase I
D) Phase III
C
